Access ControlFeaturedTechnology

7. Suprema BioStar 2 acquires data protection certifications ISO 27001 and ISO 27701

Suprema, a global leader in access control, biometrics and time & attendance solutions, announced today that its BioStar 2 platform acquired ISO 27001 and ISO 27701 certifications, internationally recognized privacy information and security standard.

ISO 27001 ensures that appropriate measures are in place for data protection and management of information. ISO 27701, first established in August last year, is granted to systems compliant with the General Data Protection Regulation (GDPR) and other similar legislations like California Consumer Privacy Act (CCPA). Both certifications are published and managed by the International Organization for Standardization (ISO).

Suprema BioStar 2 that acquired the ISO certifications, is a web-based open platform with access control, time and attendance and visitor management features. Suprema offers API and SDK that enables BioStar 2’s easy integration with third party systems.

Suprema BioStar 2 met all of the 26 data protection management standards, 114 data protection control and 18 personal information management requirements for the certifications.

“Suprema has been striving to strengthen the security level of not just our products and solutions but the company as a whole. We’ve expanded our security team and are running a data protection system in line with global security compliance standards, providing safe and secure solutions. I’m glad to have the ISO 27001 and 27701 certifications validate our efforts,” said Young S. Moon, the CEO of Suprema Inc.

 

 

Related posts

Idemia suspension in Kenya overturned, local solutions sought for cybercrime

admin

Hikvision launches the next-generation Turbo HD 8.0, opening a new chapter in audio-visual fusion

admin

How To Establish And Maintain An Effective Physical Access Control

admin

Leave a Comment

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More